Research map: Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes

Back to the article

Papers in this map

  1. The Clinical Dementia Rating (CDR) · John C. Morris · 1993 · 10097 citations · Cited by this paper
  2. The Challenge of Atypical Alzheimer Disease Phenotypes · Călin I. Prodan · 2026 · Cites this paper
  3. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy · 2026 · Related
  4. Lecanemab in Early Alzheimer’s Disease · Christopher H. van Dyck · 2022 · 5709 citations · Cited by this paper
  5. Convulsions, Palsy, and the Spanish Inquisition · 2026 · Related
  6. Classification of primary progressive aphasia and its variants · Maria‐Luisa Gorno‐Tempini · 2011 · 5246 citations · Cited by this paper
  7. Natural History of Adult-Onset Myotonic Dystrophy Type 1 · 2026 · Related
  8. Donanemab in Early Symptomatic Alzheimer Disease · John Randall Sims · 2023 · 2897 citations · Cited by this paper
  9. Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis · 2026 · Related
  10. Criteria for the diagnosis of corticobasal degeneration · Melissa J. Armstrong · 2013 · 1964 citations · Cited by this paper
  11. Child Neurology: Early-Onset, Rapidly Progressive, and Refractory DYT- TOR1A Status Dystonicus · 2026 · Related
  12. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease · Rik Ossenkoppele · 2016 · 1268 citations · Cited by this paper
  13. Teaching NeuroImage: Utility of Arterial Spin Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH · 2026 · Related
  14. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study · Melissa Erin Murray · 2011 · 1011 citations · Cited by this paper
  15. Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD · 2026 · Related
  16. Defining imaging biomarker cut points for brain aging and Alzheimer's disease · Clifford R. Jack · 2016 · 1002 citations · Cited by this paper
  17. Central Obesity and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnea · 2026 · Related
  18. New insights into atypical Alzheimer's disease in the era of biomarkers · Jonathan Graff‐Radford · 2021 · 701 citations · Cited by this paper
  19. Vamorolone for Duchenne Muscular Dystrophy · 2026 · Related
  20. Consensus classification of posterior cortical atrophy · Sebastian James Crutch · 2017 · 679 citations · Cited by this paper
  21. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy · David F. Tang‐Wai · 2004 · 639 citations · Cited by this paper
  22. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease · Salvatore Spina · 2021 · 285 citations · Cited by this paper
  23. White matter hyperintensities: relationship to amyloid and tau burden · Jonathan Graff‐Radford · 2019 · 259 citations · Cited by this paper
  24. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum · David Thomas Jones · 2017 · 247 citations · Cited by this paper
  25. Donanemab: Appropriate use recommendations · G D Rabinovici · 2025 · 230 citations · Cited by this paper
  26. Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes · Sergey Shcherbinin · 2022 · 211 citations · Cited by this paper
  27. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease · Michael Schöll · 2017 · 188 citations · Cited by this paper
  28. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease · Jennifer A. Zimmer · 2025 · 166 citations · Cited by this paper
  29. Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes · Ryan A. Townley · 2020 · 155 citations · Cited by this paper
  30. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging · Rioghna R. Pittock · 2023 · 151 citations · Cited by this paper
  31. Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET · Renaud La Joie · 2020 · 138 citations · Cited by this paper
  32. Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease · Vijay K. Ramanan · 2023 · 108 citations · Cited by this paper
  33. Lecanemab Treatment in a Specialty Memory Clinic · Madeline Paczynski · 2025 · 98 citations · Cited by this paper
  34. Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading · Lukas K. Frontzkowski · 2022 · 95 citations · Cited by this paper
  35. CSF biomarkers in posterior cortical atrophy · Jérémie Seguin · 2011 · 86 citations · Cited by this paper
  36. Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) · Hanna Cho · 2023 · 86 citations · Cited by this paper
  37. Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia · Gregory Scott Day · 2017 · 72 citations · Cited by this paper
  38. Aducanumab: Appropriate use recommendations · Jeffrey L. Cummings · 2021 · 65 citations · Cited by this paper
  39. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression · Leon Aksman · 2023 · 55 citations · Cited by this paper

Source: OpenAlex (CC0)